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In the hindbrain, generation of the facial nucleus involves complex developmental processes that will lead to the formation of a structure
composed of motor neurons, astrocytes and oligodendrocytes. The implication of LIF-related cytokines in the development of this nucleus came to
light with the analysis of mice mutant for the receptor of these cytokines, LIFRβ, which exhibit a massive loss of facial branchiomotor (fbm)
neurons at birth and a severe decrease in GFAP expression, a marker of astrocytes. To uncover the cellular mechanisms regulated by LIFRβ during
facial nucleus development, we first analyzed its expression pattern in the hindbrain. lifrβ is first expressed at E11.5 in the hindbrain
neuroepithelium. The receptor is absent during the migration of fbm post-mitotic neurons but is strongly expressed when fbm neurons have reached
rhombomere 6 at E12.5, and its expression is maintained until E18.5. From the analysis of lifrβ mutant embryos, we established that LIFRβ is
necessary for fbm neurons’ identity determination. We also show that LIFRβ is implicated in astrocyte and oligodendrocyte differentiation,
specifically within the facial nucleus.
© 2007 Elsevier Inc. All rights reserved.Keywords: Cytokine; Motor neuron; Astrocyte; Oligodendrocyte; lifrβ mutant mice; Facial nucleus; Hindbrain developmentIntroduction
Development of the central nervous system (CNS) is go-
verned by multi-step processes in which neurons, astrocytes and
oligodendrocytes are generated from common neural stem cells.
Specification and differentiation of these populations result from
an interplay between intrinsic genetic mechanisms and extrinsic
cues such as growth factors. Among these factors, members of
the IL-6 cytokine family including LIF, CNTF, CLC and CT-1,
also called LIF-related cytokines, have been shown to play a
central role in the developing nervous system (Bauer et al.,
2007). These cytokines signal through a receptor complex
consisting of the heterodimerization of LIFRβ and gp130 (for
review, see Ip and Yancopoulos, 1996; Murphy et al., 1997).
This dimerization triggers the activation of several intracellular⁎ Corresponding author. Fax: +33 491 820 682.
E-mail address: durbec@ibdml.univ-mrs.fr (P. Durbec).
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doi:10.1016/j.ydbio.2007.10.020signal transduction cascades including the JAK/STATand MAP
kinase pathways (for review, see Turnley and Bartlett, 2000).
LIFRβ functional implication in neuronal and glial devel-
opment has been studied both in vivo and in vitro. Mutant mice
for LIFRβ show a massive loss of motor neurons at birth both in
the facial nucleus and the spinal cord (Li et al., 1995), high-
lighting a major role for these cytokines and their receptors in
CNS neuronal development. Nevertheless, little is known about
the exact processes affected during motor neuron development
in these mutant mice. Further analyses have clearly established
that LIFRβ is also implicated in the development of astrocytes
(Barnabe-Heider et al., 2005; Ware et al., 1995). These studies
demonstrate that LIFRβ mutant embryos completely lack
GFAP expression, a marker of mature astrocyte, in spinal
cord and hindbrain (Ware et al., 1995). This phenotype is due to
the implication of LIFRβ signalling pathway in the initiation of
GFAP expression, but not in the determination of astrocyte cell
fate (Bonaguidi et al., 2005). A further analysis has also estab-
lished that CT-1, one of LIFRβ ligands, is essential for the
initiation of gliogenesis in vitro (Barnabe-Heider et al., 2005).
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development has been investigated, little is known about the
exact role of this pathway during development of the other
major subtype of glial cells, oligodendrocytes. Most of the
studies have been performed in the adult, revealing the role of
the IL-6 cytokine family in oligodendrocyte survival and
remyelination in case of injury (Azari et al., 2006; Bauer et al.,
2007; Butzkueven et al., 2002, 2006; Ishibashi et al., 2006; Kerr
and Patterson, 2005). The implication of these cytokines during
oligodendrocyte development is thus still to be discovered.
To understand the role of LIFRβ in multi-step developmental
processes leading to the generation of neuronal and glial line-
ages, we examined lifrβ expression pattern and studied its role
during facial nucleus development in mouse. Here we show
that, at late developmental stages, lifrβ is expressed in mature
motor neurons, but not in glial cells. However, via the analysis
of lifrβ mutant embryos, we establish that LIFRβ is necessary
for motor neuron, astrocyte and oligodendrocyte development
in the facial nucleus at late embryonic stages.
Materials and methods
Animals and genotyping analysis
All procedures involving the use of animals were performed in accordance
with the European Community Council Directive of 24 November 1986 on the
protection of animals used for experimental purposes (86/609/EEC). Hetero-
zygous lifrβ+/− mice (Ware et al., 1995) (strain B6, 129-Lifrtm1Imx) from the
Jackson Laboratory (Bar Harbor, ME) were backcrossed to CD1mice for at least
six generations and mated to obtain homozygous or heterozygous embryos; wild
type embryos from the same litters were used as controls. The day of the positive
vaginal plug was recorded as E0.5. Genotype analysis of lifrβ mutant, hetero-
zygous and wild type embryos was performed as described in Arce et al. (1999).
In situ hybridization
Whole mount in situ hybridizations (ISH) were performed on brainstem as
described (Garces et al., 2000), with digoxigenin-labelled RNA. Digoxigenin
detection with alkaline phosphatase-conjugated antibody (Roche 1/2000) was
followed by NBT/BCIP staining (Roche). Rat isl-1 probe was provided by T.M.
Jessell (Columbia University, NY, USA); mouse phox2a, phox2b and nkx2.2
were provided by C. Goridis (ENS Paris, France); and mouse lifrβ probe was
described previously (Arce et al., 1998).
Double ISH on frozen sections were performed using lifrβ, β-galactosidase
(provided by P. Lemaire, Marseille, France) and plp/dm20 (Peyron et al., 1997)
cDNAs labelled with Fluorescein-UTP and pdgfrα (Mudhar et al., 1993), sox10
(Kuhlbrodt et al., 1998), olig2 (Lu et al., 2000), and nkx2.2 (provided by C.
Goridis) cDNAs labelled with DIG–UTP. Fluorescein-labelled probes were de-
tected with an anti-fluorescein antibody coupled to horseradish peroxidase
(Roche 1/2000) and the signal was amplified with a Tyramide Signal Ampli-
fication (TSA) Plus Fluorescein Kit (NEL741B001KT; Perkin-Elmer) according
to the manufacturer’s protocol (6-min incubation in fluorophore tyramide
working solution). The anti-fluorescein–HRP is then removed by a 15-min
incubation at 70 °C in formamide/SSC buffer (50% formamide, 2× SSC, 0.1%
Tween-20). After extensive washes (3×5 min and 1×30 min) in TNT buffer
(0.1 M Tris–HCl pH 7.5, 0.15 M NaCl, 0.1% Tween-20), the DIG-labelled
probe is detected by an anti-DIG–HRP antibody (Roche 1/2000), amplified in
the same way with Tyramine Signal Amplification (TSA) Plus Cyanine 3 Kit.
Immunohistochemistry
The following primary antibodies were used: rabbit anti-Olig2 (1/250; Che-
micon), rabbit anti-S100β (1/300; Dako), mouse anti-GFAP (1/1000; Sigma),rabbit anti-ER81 (gift from T. Jessell; 1/4000), guinea pig anti-Lhx-4 (gift from
T. Jessell; 1/400), rabbit anti-Phox2a (gift from C. Goridis; 1/100), rabbit anti-
Phox2b (gift from C. Goridis; 1/1000), mouse anti-Islet1/2 (39-4D5, 1/100; 40-
2D6, 1/500; from the Developmental Studies Hybridoma Bank), and rabbit anti-
Isl1/2 (gift from T. M. Jessell; 1/1000).
For immunolabelling on tissue sections, the slides were briefly washed in
PBS, followed by 1-h incubation at RT in blocking buffer (10% FCS, 0.2%
BSA, 0.1% Triton X-100 in PBS). Tissue sections were then incubated overnight
at 4 °C in primary antibody diluted in the blocking solution. The sections were
subsequently washed and incubated with the appropriate fluorescently labelled
secondary antibodies (1:1000; Jackson Immunoresearch Laboratories, West
Grove, PA, USA) for 1–2 h at room temperature. Cell nuclei were stained with
Hoechst 33342 (1/1000; Sigma).
Following in situ hybridization, staining with antibodies were performed on
the same sections. The slides were washed three times 10 min in PBS, followed
by 1-h incubation at RT in blocking buffer (10% FCS, 0.2% BSA, 0.1% Triton
X-100 in PBS). The slides are incubated overnight at 4 °C with the appropriate
primary antibody. Sections are washed 3 times 10 min in PBS (RT) and then
incubated with the appropriate fluorescently labelled secondary antibodies
(1:1000; Jackson Immunoresearch Laboratories) for 1–2 h at room temperature.
Cell nuclei were stained with Hoechst 33342 (1/1000; Sigma).
For immunolabelling on whole brainstems, brainstems were dissected in
cold PBS and fixed 2 h at 4 °C in 4% PFA. The samples were washed in PBS,
followed by 1-h incubation at RT in blocking buffer (10% FCS, 0.2% BSA,
0.1% Triton X-100 in PBS). The samples were then incubated 48 h at 4 °C in a
primary antibody solution (primary antibody diluted in the blocking solution).
Brainstems were subsequently washed for 24 h at 4 °C in PBS/0.1% Triton X-
100 and incubated with the appropriate fluorescently labelled secondary
antibodies (1:1000; Jackson Immunoresearch Laboratories) for 48 h at 4 °C.
Samples were then washed for 24 h at 4 °C in PBS, 0.1% Triton X-100. Cell
nuclei were stained with Hoechst 33342 (1/1000; Sigma). Brainstems are then
incubated overnight at 4 °C in PBS/80% glycerol and flat mounted in this
medium.
Fluorescent microscopy, quantification and statistical analysis
Whole brainstems were analysed using confocal imaging with the LSM 510
imaging system (Zeiss). Brainstems cryostat sections were examined using
confocal imaging with the Apotome imaging system (Zeiss). All motor neurons
counting were performed on digital sections taken every 6 μm from whole
mount preparations. All glial cells counting were performed on confocal
images from cryostat sections. The number of positive cells for a given marker
was counted on 1 out of 3 sections per embryo. All quantifications were
performed on at least 3 embryos per genotype. Each positive cell was examined
in its entire z-axis in order to exclude false double labelling due to an overlay
of signals from different cells. Counts are presented as mean±standard error of
the mean (S.E.M.). Statistical analyses were performed with t-tests using the
SigmaStat software (SPSS, USA).Results
lifrβ is expressed during facial nucleus development
During facial nucleus formation, fbm neural progenitors are
generated between E9.5 and E12.5 (Altman and Bayer, 1980;
Auclair et al., 1996; Pierce, 1973). Then, fbm neurons undergo a
complex migration in the mouse embryonic hindbrain, that we
followed using isl1, a marker of post-mitotic fbm neurons (Pfaff
and Kintner, 1998; Figs. 1C, E, G, I, and K). From E10, fbm
neuron cell bodies start migrating from r4 tangentially along the
lateral margin of the floor plate, reaching first r5 and
subsequently r6 (not shown and Figs. 1C and E). In a second
wave of migration, fbm neurons start a lateral migration,
moving away from the rhombencephalon ventricular zone (VZ),
Fig. 1. lifrβ is dynamically expressed during facial nucleus development. (A, B)
ISH on whole brainstems with a lifrβ probe at E9.5 (A) and E10.5 (B) showing
that lifrβ is not expressed at these stages. OV, ottical vesicle. (C–L) ISH on
whole brainstems with is1l (C, E, G, I, K) and lifrβ probes (D, F, H, J, L). (C, D)
At E11.5, is1l is expressed in post mitotic fbm neurons migrating from r4
through r5 to r6 (C, black arrow), whereas lifrβ is detected only as a narrow
column in the ventricular zone (D, VZ, black arrow) all along the A–P axis.
(E, F) At E12.5, isl1 is expressed in all fbm neurons all along their migratory
stream and also in neurons that have finished to migrate and started to form the
facial nucleus in r6 (E, black arrow). At this stage, lifrβ is still expressed in the VZ
(F, black arrow). It is not detected in post mitotic motor neurons in rhombomere 4
andweakly in rhombomere 5 but it is expressed in r6where the facial nucleus will
form (F, arrowhead). (G, I, K) isl1 is expressed in all fbm neurons during sub-
nuclei segregation from E14.5 to E18.5. (H, J, L) lifrβ is detected in the facial
nucleus at E14.5, E16.5 and E18.5, showing a stronger expression in the
intermediate sub-nucleus (black arrow). Scale bars: A–L=500 μm.
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forming the facial motor nucleus. The first fbm neurons to reach
this final destination are detected at E12.5 (Fig. 1E), and thefacial motor nucleus migration is completed around E14.5 (Fig.
1G; Garel et al., 2000; Studer, 2001; Cordes, 2001; Chan-
drasekhar, 2004). Subsequently, fbm neurons start to segregate
into motor neuron pools called sub-nuclei (Figs. 1G, I and K;
Ashwell and Watson, 1983).
In order to determine lifrβ expression pattern during facial
nucleus formation, we performed in situ hybridization (ISH) on
whole brainstems using a lifrβ probe (Figs. 1A, B, D, F, H, J and
L) and compared it to isl1 staining (Figs. 1C, E, G, I and K).
lifrβ is clearly not expressed in the hindbrain at E9.5 (Fig.
1A) and E10.5 (Fig. 1B). Its expression was first detected at
E11.5, labelling a narrow column in the rhombencephalon VZ
(Fig. 1D), all along the anterior–posterior (A–P) axis. In con-
trast, isl1 was expressed in post-mitotic fbm neurons but not in
the floor plate (Figs. 1C and E; Pfaff and Kintner, 1998). At
E12.5, lifrβ was still detected in the VZ, but also in r6, where
fbm neurons start to form the facial nucleus (Fig. 1F). From
E14.5 to E18.5, lifrβ was expressed in the facial nucleus, but
stronger in its intermediate part (Figs. 1H, J and L).
These data show that lifrβ is dynamically expressed in the
hindbrain during facial nucleus development. It is first detected
as a narrow column in the VZ at E11.5, then absent during the
r4–r5 migration of post-mitotic neurons, and finally strongly
expressed at E12.5 in r6, where fbm neurons will form the facial
nucleus. lifrβ expression is then maintained while fbm neurons
maturate, generating the facial sub-nuclei.
Lifrβ is expressed in mature motor neurons but is not detected
in mature glial cells in the E18.5 facial nucleus
To uncover the role of LIFRβ during facial nucleus form-
ation, we have focused our work on late stages, when lifrβ is
strongly expressed in the developing facial nucleus.
From E14.5, fbm neurons start to segregate, generating sub-
nuclei that will innervate specific muscular targets (Ashwell and
Watson, 1983). At E18.5, we can thus distinguish the lateral,
intermediate and medial sub-nuclei (Fig. 2A). We wished to
identify the cells in which lifrβ was expressed at late deve-
lopmental stages on transverse section of the E18.5 facial
nucleus (Fig. 2). We showed co-expression of lifrβ with Isl1 in
all mature fbm neurons, mainly in the intermediate sub-nucleus,
and weaker in medial and lateral sub-nuclei at this stage (Figs.
2B–C). Combined labelling for lifrβ and either S100β (marker
of astrocytes; Schmidt-Kastner and Szymas, 1990), or pdgfrα
(marker of oligodendrocytes; Liu et al., 2002), revealed no lifrβ
staining in glial cells at E18.5 (Figs. 2D–G). Thus, these data
show that, at late developmental stages of the facial nucleus,
lifrβ is expressed in mature motor neurons, but is not detected
in glial cells.
LIFRβ signalling is not necessary for the generation of fbm
neurons
A previous study described a loss of 40% of fbm neurons in
newborns lacking LIFRβ (Li et al., 1995), suggesting a role for
this receptor in fbm neurons’ development. lifrβ was first de-
tected at E11.5 in the ventricular zone (Fig. 1D). It could
Fig. 2. lifrβ is expressed in mature fbm neurons but absent frommature glial cells in the E18.5 facial nucleus. (A) Schematic representation of the E18.5 hindbrain, with
the facial nucleus in grey, the lateral sub-nucleus in green, the intermediate one in yellow and the medial one in pink. Representation of the whole brain stem on the
right and representation of a transverse section of the facial nucleus on the bottom left. (B, C) Double labelling for lifrβ and Isl1 on transverse sections of the E18.5
facial nucleus illustrates lifrβ expression in Isl1 positive fbm neurons (C, white arrow). (D–G) Double labelling for lifrβ and pdgfrα (D, E) and for lifrβ and S100β (F,
G) on transverse sections of the E18.5 facial nucleus shows that lifrβ is expressed neither in oligodendrocytes (pdgfrα+ cells) nor in astrocytes (S100 β+ cells). (B, D, F)
Lateral is left and medial is right. Scale bar: 50 μm.
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We thus analysed the expression pattern of various markers of
neuronal progenitors and post-mitotic neurons at E11.5 and
E12.5 in r4 (Fig. 3). We performed double staining on r4
hindbrain sections at E11.5 (Figs. 3A and B) and E12.5 (data
not shown) using nkx2.2 and Phox2b. We observed that, at both
stages, the expression pattern of these two markers was not
modified in lifrβ−/− compared to lifrβ+/+ embryos. Whole
mount hindbrain ISH with nkx.2.2 (Figs. 3C and D), phox2b
(Figs. 3E and F), phox2a (Figs. 3G and H) and isl1 (Figs. 3I and
J) at E12.5 revealed no difference at this stage in mutant
compared to control embryos. Consistent with these data, no
significant changes in the total number of Isl1+ fbm neurons
were observed in the absence of LIFRβ signalling at E12.5 (Fig.
4A). Interestingly, using phox2b (Figs. 3E and F) and isl1 (Figs.
3I and J) staining at this specific stage, no modification in the
stream of migrating neurons from r4 to r6 was observed in
lifrβ−/− compared to lifrβ+/+ embryos. Altogether, these data
suggest that generation of fbm neurons in absence of LIFRβ
signalling is not affected.
LIFRβ signalling is necessary for fbm neurons’ identity
determination
To elucidate the implication of LIFRβ signalling in fbm neu-
rons’ identity determination, we first studied the expression
patterns of two markers of fbm neurons, Isl1 and Phox2b, in
lifrβ+/+ and lifrβ−/− embryos between E12.5 and E18.5. Immu-
nofluorescent staining with Isl1 on whole brainstems revealed
no obvious difference in the expression of this marker fromE12.5 to E18.5 (Supplementary Figs. 1A–H). Consistent with
these data, counting on optical sectioning of these preparations
showed no significant change in the total number of Isl1+ fbm
neurons in the absence of LIFRβ signalling at these stages
(Fig. 4A).
Using Phox2b as a second marker for fbm neurons, no
obvious defects were observed at E12.5 in lifrβ−/− compared to
lifrβ+/+ embryos (Supplementary Figs. 1I and J). Surprisingly,
although Phox2b is known to be a marker of all fbm neurons
(Pattyn et al., 1997, 2000), a remarkable decrease in Phox2b
expression was observed in E14.5 and E16.5 lifrβ−/− embryos,
compared to lifrβ+/+ at the same stages (Supplementary Figs.
1K–N). In line with these results, the expression of Phox2a, a
marker of fbm neurons that is downstream of Phox2b in its
signalling pathway (Pattyn et al., 2000), was decreased in
lifrβ−/− embryos compared to their wild type littermates at the
same stages (Figs. 4B–E).
To examine the expression pattern of Phox2a and Phox2b
specifically in lifrβ−/− cells, we took advantage of the fact that
the lifrβ deleted gene was replaced by a lacZ/neo cassette in the
lifrβ mouse line (Ware et al., 1995). We thus performed com-
bined labelling for β-galactosidase and Phox2a on E14.5 facial
nucleus transverse sections. These experiments revealed a
severe reduction of Phox2a expression in lifrβ−/− compared to
lifrβ+/− cells (Figs. 4F–I). Similarly, co-labelling for β-galac-
tosidase and Phox2b on E14.5 transverse sections showed a
reduction of Phox2b expression in lifrβ−/− compared to lifrβ+/−
cells (Figs. 4J–M). Consistent with these results, using double
staining for Isl1 and either Phox2a (Figs. 4N–Q), or Phox2b
(Figs. 4R–U), on E16.5 transverse sections, we observed a
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lifrβ−/− compared to lifrβ+/+ embryos.
Overall, these results show that, in the absence of LIFRβ
signalling, whereas the correct number of Isl1+ neurons is
present in the facial nucleus, Phox2a and Phox2b expressions
are severely altered once all the fbm neurons have reached r6
and start to segregate into sub-nuclei. These data suggest a
modification in the combination of genes expressed by fbm
neurons during their maturation in absence of LIFRβ signalling.
To go further with these results and to better understand how
fbm neurons develop in a LIFRβ mutant context, we examined
the expression pattern of specific markers of motor neuron sub-
populations in the facial nucleus.
To this end, we analyzed the expression patterns of ER81, a
transcription factor of the ETS gene family (Arber et al., 2000),
and Lhx4, a LIM homeobox-containing transcription factor
(Sharma et al., 1998), two markers known to be expressed in
fbm neurons’ sub-populations (Gavalas et al., 2003). In contrast
to Lhx4 that is not altered in the mutant (Figs. 5E–H, J and K–
L), ER81 expression domain is expanded towards a medial
position (Figs. 5A–D and K–L) as seen by immunohistochem-
istry at E16.5 and E18.5.
To examine the ER81+ sub-population during development,
we counted ER81+ cells on confocal optical sections from whole
mount preparations at different embryonic stages (Fig. 5I). At
E14.5, there were no differences between lifrβ−/− and lifrβ+/+
facial nuclei whereas later on at E16.5, the number of ER81+
cells in the facial nucleus of lifrβ−/− embryos (602±90, n=4)
was increased by 85% relative to lifrβ+/+ embryos (323±69,
n=4, pb0.05). At E18.5, the number of ER81+ cells decreased
in both genotypes but there was still a 70% increase in lifrβ−/−
compared to lifrβ+/+ facial nuclei (333±19 and 193±53, res-
pectively; n=4; pb0.05). Consistent with these results, immu-
nofluorescent staining performed on E16.5 transverse sections
revealed that Isl1-positive cells that do not express ER81 in
lifrβ+/+ embryos (Fig. 5K), express this gene in lifrβ−/− ones
(Fig. 5L). Moreover, double staining for ER81 and Lhx4 on
these sections (Figs. 5K and L) did not show any intermingling
between ER81+ and Lhx4+ cells in a lifrβ mutant context,
suggesting that, concerning the analysed motor pools, fbm
neurons’migration is not affected during sub-nuclei segregation
in lifrβ−/− embryos compared to lifrβ+/+.
In conclusion, although the total number of fbm neurons
does not change during development in absence of lifrβ, the
expression of specific motor neuron markers can be drastically
altered (Phox2a, Phox2b and ER81) or unchanged (Isl1, Lhx4).
Therefore, there is a modification in the combination of genesFig. 3. fbm neurons generation is not affected in the absence of LIFRβ
signalling. (A, B) Fluorescent ISH with nkx2.2 probe combined with immu-
nostaining for Phox2b on r4 transverse section from E11.5 embryos shows a
similar pattern in lifrβ+/+ (A) and lifrβ−/− (B), illustrating the correct specification
of fbm neuron progenitors in the mutant context. Pictures are centred either on
the left (A) or on the right side (B) of the ventricular zone. (C–J) ISH on whole
mount brainstems from lifrβ+/+ (C, E, G, I) and lifrβ−/− (D, F, H, J) E12.5
embryos with either nkx2.2 (C, D), phox2b (E, F), phox2a (G, H) or isl1 (I, J),
illustrate the absence of defects at early stages in absence of lifrβ signalling.
Scale bar: (A–B) 50 μm; (C–J) 500 μm.
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data show that LIFRβ signalling plays a crucial role in the
determination of fbm neurons’ identity during their maturation.
The number of glial cells is reduced in the E18.5 facial nucleus
of lifrβ-deficient embryos
In order to analyse the development of glial cell populations
in absence of LIFRβ signalling in the facial nucleus, we
examined both astrocyte and oligodendrocyte lineages in late
lifrβ−/− embryos compared to lifrβ+/+ (Fig. 6 and Table 1). We
quantified at E16.5 and E18.5 the number of Olig2+, pdgfrα+
and sox10+ cells, three oligodendrocyte-specific markers and
the number of S100β+ cells, identified as astrocytes. No changes
in the expression and number of S100β+ cells and Olig2+ cells
were observed comparing E16.5 lifrβ−/− and lifrβ+/+ embryos
(Table 1 and Figs. 6A and B).
Remarkably, we observed 40% less oligodendrocytes in
lifrβ−/− E18.5 facial nuclei compared to lifrβ+/+ littermates
(Olig2+, sox10+ and pdgfrα+ cells, Table 1 and Figs. 6C and D).
The number of S100β+ astrocytes was also reduced by 27% in
lifrβ−/− E18.5 facial nuclei compared to lifrβ+/+ (Table 1; Figs.
6E and F) in accordance with a significant decrease in GFAP
expression (Figs. 6G and H; Ware et al., 1995).
These results show that both astrocyte and oligodendrocyte
development are impaired in lifrβ−/− embryos compared to
lifrβ+/+, and suggest a defect in glial differentiation in the
absence of LIFRβ signalling.
Strikingly, these data reveal a very paradoxical situation:
Although lifrβ is not expressed at E18.5 in astrocytes and
oligodendrocytes, the defects due to the absence of lifrβ are
only observed at this stage. This phenotype could be explained
either by an early quiescent modification in glial precursor cells,
or to a late indirect effect of lifrβ expressing fbm neurons on
glial cells. To test these hypotheses, we counted the number of
sox10+, pdgfrα+ and S100β+ cells at the same A–P level as the
facial nucleus, but outside this structure. Indeed, since glial cells
migrate radially from the VZ (Thomas et al., 2000), if the
precursors are altered, the defects should be observed in all glial
cells coming from the r6 VZ. Remarkably, in these regions of
the E18.5 hindbrain outside the facial nucleus, no differences in
the number of sox10+, pdgfrα+ and S100β+ cells were observed
(Table 1).
Overall, we show that, at this given A–P level of the
hindbrain originating from r6, the number of both astrocytes and
oligodendrocytes is specifically reduced in the facial nucleus of
E18.5 lifrβ−/− embryos compared to lifrβ+/+. In sharp contrast,Fig. 4. Phox2a and Phox2b expressions are affected in the facial nucleus of lifrβ−/−
nucleus development, from E12.5 to E18.5. Cell counting was performed on confo
difference in the number of Isl1 positive cells was observed during facial nucleus de
views showing a severe reduction in Phox2a expression in lifrβ−/− facial nuclei comp
for β-gal combined with immunohistochemistry either for Phox2a (F–I) or for Phox2
lifrβ positive cells (β-gal+ cells) express Phox2a (F, white arrow in panel G) and Phox
(H, white arrow in panel I) and a partial loss of Phox2b (L, white arrow in panel M). (
(R–U) on E16.5 facial nucleus transverse sections. In lifrβ+/+ embryos, Isl1+ cells ex
lifrβ−/− embryos, isl1+ cells show a loss of Phox2a (P, Q, white arrow) and a reduction
left and medial is right. Scale bars: 50 μm.gliogenesis is correctly occurring at the same level of the hind-
brain but outside the facial nucleus, the number of glial cells
being unaffected in E18.5 lifrβ−/− embryos compared to lifrβ+/+.
This suggests that the effect of LIFRβ signalling upon glial
differentiation is indirect.
Discussion
In this study, we have established that LIFRβ is a key regu-
lator of specific processes involved both in neuronal and glial
development leading to facial nucleus formation in the mouse
hindbrain. We showed that LIFRβ signalling is not required for
the specification of motor neuron, astrocyte and oligodendro-
cyte, in a first phase of facial nucleus development. However, in
a second step, fbm neurons’ identity is modified and the number
of generated astrocytes and oligodendrocytes is reduced in
absence of LIFRβ signalling. Our study thus shows that
signalling via LIFRβ exerts important influences upon motor
neuron identity determination and glial differentiation during
mouse facial nucleus development.
LIFRβ signalling is not required for neuronal and glial early
specification in the facial nucleus
Previous studies showed that lifrβ is expressed in brain
neuroepithelium (Gregg andWeiss, 2005), but is not involved in
neural stem cell proliferation and survival (Shimazaki et al.,
2001; Pitman et al., 2004; Ohtani et al., 2000). Here, we con-
firmed that lifrβ is not functionally involved in the specification
of neuronal and glial cells. Indeed, in the absence of LIFRβ
signalling, neither the number of fbm neurons nor the number of
immature glial cells generated was altered during facial nucleus
formation. These in vivo data demonstrate that LIFRβ is not
involved in the early steps of neurogenesis and gliogenesis
during facial nucleus development.
LIFRβ signalling is necessary for the determination of motor
neuron identity within the facial nucleus
Immediately after exit from the neuroepithelium in r4, fbm
neurons migrate tangentially to their final position in r6. Here
we show that fbm neurons do not express LIFRβ during this
migration step and this process is not affected in mutant
embryos. These results indicate that LIFRβ signalling pathway
is not necessary for fbm neurons’ early specification and mig-
ration towards their final destination in r6. During the next
phase of facial nucleus formation, at a time when sub-nucleiembryos. (A) Quantification of the number of Isl1 positive cells during facial
cal (LSM 510, Zeiss) optical sectioning from whole brainstems. No significant
velopment between lifrβ−/− and lifrβ+/+ embryos. (B–E) Whole mount confocal
ared to wild type both at E14.5 (B, C) and E16.5 (D, E). (F–M) Fluorescent ISH
b (J–M) on E14.5 transverse sections of the facial nucleus. In lifrβ+/− embryos,
2b (J, white arrow in panel K) whereas lifrβ−/− cells show a total loss of Phox2a
N–U) Immunofluorescent staining for Isl1 with either Phox2a (N–Q) or Phox2b
press Phox2a (N, O, white arrow) and Phox2b (R, S, white arrow), whereas in
in Phox2b expression (T, U, white arrow). (B–E, F, H, J, L, N, P, R, T) Lateral is
Fig. 5. fbm neurons' identity is altered in the absence of LIFRβ signalling. (A–H)Whole mount confocal views showing immunofluorescent staining for ER81 (A–D)
and Lhx4 (E–H) in the facial nucleus of lifrβ+/+ (A, C, E, G) and lifrβ−/− (B, D, F, H) embryos. (A–D) ER81 expression domain is extended in the facial nucleus of
lifrβ−/− embryos (B, D) compared to their lifrβ+/+ littermates (A, C) at E16.5 (A, B) and E18.5 (C, D). (E–H) No obvious difference in the expression of Lhx4 is noticed
in lifrβ−/− embryos (F, H) compared to wild type (E, G) during development. (I, J) ER81+ and Lhx4+ cells were quantified during the development of the facial nucleus
on confocal image stacks (LSM 510, Zeiss) after immunohistochemistry on whole brainstems. The number of ER81+ cells is considerably increased in lifrβ−/− facial
nuclei compared to lifrβ+/+ (I, 86.3% and 72.6% more ER81+ cells in lifrβ−/− facial nuclei at E16 and E18, respectively; t test, pb0.05). No significant difference in the
number of Lhx4+ cells is observed comparing lifrβ−/− to wild type (J). (K, L) Immunofluorescent staining for ER81, Isl1 and Lhx4 on E16.5 facial nucleus transverse
sections shows that Isl1+ cells that do not express ER81 in a lifrβ+/+ context (K) express this gene in lifrβ−/− embryos (L, white arrows). (A–H, K, L) Lateral is left and
medial is right. Scale bars: 50 μm.
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Fig. 6. Glial differentiation is affected in lifrβ−/− embryos. (A–D) Analysis of oligodendrocyte differentiation in the facial nucleus of lifrβ−/− embryos (B, D) compared
to wild type (A, C) at E16.5 (A, B) and E18.5 (C, D). Whereas Olig2 expression is not affected in lifrβ−/− embryos at E16.5 (A, B), a reduction in Olig2 expression is
obvious in lifrβ−/− embryos (D) compared to wild type (C) at E18.5. (E–H) Analysis of astrocyte differentiation in the facial nucleus of lifrβ−/− embryos at E18.5. At
E18.5 in the mutant facial nucleus as compared to wild type, S100β expression is slightly reduced (E, F) whereas GFAP expression is severely reduced (G, H). (A–H)
Lateral is left and medial is right. Scale bars: 50 μm.
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this process, the combinatorial expression of transcription
factors will define motor neuron identity. We observed that
expression of motor neuron markers was either altered (Phox2a,
Phox2b and ER81) or unaffected (Isl1, Lhx4) in the mutant
context during this second phase of facial nucleus development.
For instance, in the absence of LIFRβ signalling, we observed
that the number of ER81+ cells is significantly increased,
leading to the expression of this gene in isl1-positive fbm
neurons that do not express ER81 in a wild type context.Thus, our data show that LIFRβ controls the determination
of motor neuron identity characterized by the combinatorial
expression of transcription factors.
Many studies have described the implication of LIFRβ in
motor neuron survival (Li et al., 1995; Oppenheim et al., 2001;
Forger et al., 2003), based on the massive cell death observed in
lifrβ mutants at birth. Here, we suggest that the alteration of
motor neuron identity in mutant embryos could lead to the cell
death observed at birth, probably due to the elimination of mis-
specified fbm neurons, at a time when facial nucleus is com-
Table 1
Astrocytes and oligodendrocytes' numbers are reduced specifically within the
E18.5 facial nucleus
E16.5 E18.5
In the facial
nucleus
In the facial
nucleus
Outside the
facial nucleus
S100β+ cells +16.1%±6.2 −25.7%±4.3⁎ −4.7%±12.9
Olig2+ cells +11.7%±20 −44.6%±4⁎⁎ ND
pdgfrα+ cells ND −37.1%±1.2⁎⁎⁎ −11.9%±6.2
sox10+ cells ND −36.5%±2.3*** 0%±6.6
The number of oligodendrocytes (Olig2+, pdgfrα+ and sox10+ cells) and
astrocytes (S100+ cells) is reduced in the E18.5 facial nucleus of lifrβ−/−
embryos compared to lifrβ+/+ but is unchanged in the E16.5 facial nucleus or at
E18.5 in a region of the hindbrain at the same A–P level as the facial nucleus,
but outside this structure.
The values shown are expressed in %±S.E.M., using the number of cells in
lifrβ+/+ embryos as 100%. Counting was performed on three embryos in each
group.
⁎ pb0.01.
⁎⁎ pb0.003.
⁎⁎⁎ pb0.001.
276 F. Alfonsi et al. / Developmental Biology 313 (2008) 267–278pletely formed and motor neuron sub-nuclei segregated. Alter-
natively, the loss of motoneurons at birth could be a con-
sequence of the absence of mature glial supporting cells (see
below).
Therefore, besides the known function of LIF-related cyto-
kines as survival factors for motor neurons (Sendtner et al.,
1991; Arakawa et al., 1990; Martinou et al., 1992; Pennica et
al., 1996), our study highlights a new function for LIFRβ in the
determination of fbm neurons’ identity during facial nucleus
development.
LIFRβ signalling is necessary for glial lineages differentiation
within the facial nucleus
Several groups have reported that LIF-related cytokines
influence gliogenesis (Barnabe-Heider et al., 2005; Bonni et al.,
1997; Koblar et al., 1998; Nakashima et al., 1999). In this study,
besides the known function of LIFRβ in the initiation of GFAP
expression (Bonaguidi et al., 2005), we demonstrate that S100β
expression is normal at E16.5, but is altered at E18.5 in the
mutant context, favouring a role for LIFRβ in astrocyte differ-
entiation and/or maturation. Consistent with our in vivo data,
the cortex of ct-1−/− newborns exhibits reduced levels of both
CD44, a marker of early astrocytes, and GFAP (Barnabe-Heider
et al., 2005).
Remarkably, our data give new insights into the role of
LIFRβ signalling on the oligodendroglial lineage in vivo. We
demonstrate that although cells have acquired their oligoden-
drocyte fate in the mutant, the number of oligodendrocytes is
reduced at E18.5, suggesting that oligodendrocyte differentia-
tion is altered in mutant facial nucleus. In line with this result, it
has been reported that LIF-related cytokines are involved in the
differentiation of immature oligodendrocytes (Mayer et al.,
1994) and that cultured precursor cells from lifrβ−/− embryos
generate fewer O4+ oligodendrocytes (Pitman et al., 2004). This
highlights a major role for LIFRβ signalling in oligodendrocytedifferentiation and/or maturation during facial nucleus devel-
opment in vivo.
We further show that the defects in glial development within
the facial nucleus are not observed in adjacent structures in the
hindbrain, where oligodendrocytes and astrocytes that derive
from the same pool of progenitors mature correctly. In line with
our observation, Koblar et al. (1998) have shown that lifrβ−/−
cells isolated from late embryos and cultured with BMP-2 can be
induced to express GFAP. This strongly suggests that other
mechanisms can support the differentiation process and that the
absence of LIFRβ signalling does not irreversibly affect the
maturation of astrocytes. Overall, these data support the notion
that the impairment in glial maturation in the absence of LIFRβ
signalling is contextual.
Herein, we show that no defects were observed in both
astrocyte and oligodendrocyte lineages at E16.5 in lifrβ−/−
compared to lifrβ +/+. However, we observe a significant loss of
both glial cell lineages specifically in the facial nucleus at E18.5.
This could suggest a direct role of LIFRβ in glial cell
development. Nevertheless, these defects are observed at a
stage when lifrβ is not expressed in these cells. Thus, one
possibility could be that LIFRβ signalling acts on astrocyte and
oligodendrocyte differentiation via a non cell-autonomous
mechanism during late facial nucleus development. In this
study, we demonstrate that in a lifrβ−/− context, motor neuron
identity is altered in the facial nucleus from E14.5. This event
could change the factors secreted and/or expressed at the
membrane by these neurons and thus modify the environment of
differentiating glia. Indeed, several groups have reported a direct
cross talk between neurons and glia (see Simons and Trajkovic,
2006; for review). As an example, secretion of TGFβ1 by
cortical neurons has been shown to enhance the number of
generated astrocytes and induce GFAP expression in these cells
(de Sampaio e Spohr et al., 2002). In the case of a direct inter-
action between neurons and oligodendrocytes, numerous growth
factors (PDGF, FGF2, IGF1 and NT3) have been implicated in
oligodendrocyte proliferation and differentiation (for review see
Simons and Trajkovic, 2006). A change in neuron identity could
also, for instance, alter the expression along the axons of
molecules known to be involved in oligodendrocyte maturation
such as NCAM (Charles et al., 2000).
Our observation could also be explained by complex indirect
interactions between neurons, astrocytes and oligodendrocytes.
Since many growth factors are secreted both by neurons and
astrocytes, the effect on oligodendrocyte development could
occur via an astrocyte/oligodendrocyte interaction and thus be a
secondary effect of motor neuron mis-specification. Other po-
pulations present in the facial nucleus could also be implicated
in these complex interactions. As an example, Kerr and Patter-
son (2005) have described that LIF can stimulate secretion of
trophic factors such as IGF-1 by ancillary cells and indirectly
promote oligodendrocyte survival.
Conclusion
Overall, our study based on a detailed analysis of lifrβ
expression pattern and the phenotype of lifrβ-deficient mice
277F. Alfonsi et al. / Developmental Biology 313 (2008) 267–278uncovers new prospective functions for LIFRβ during devel-
opment. We specifically highlight a potential role for LIFRβ in
the determination of motor neuron identity, and a new role for
LIF-related cytokines and their receptors, which besides their
survival activity, also play an instructive role for the maturation
of neuronal subtypes in the CNS.
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